Buyout Watch: Who's Offering What
Gimme My Discount! Deals for Feds
Retirements Rise
Insufficient Insourcing Data?
Pension Cuts Add Up to $44B in Deficit Reduction
Government's Moneyball Moment
House committee approves biodefense measure
- By Kristen A. Lee
- September 21, 2006
- Comments
The Biodefense and Pandemic Vaccine and Drug Development Act of 2006 (H.R. 5533), expands on Project BioShield, which was signed into law two years ago.
The bill establishes a point of authority in the federal government -- the Biomedical Advanced Research and Development Authority -- to coordinate and facilitate efforts to develop countermeasures for bioterrorism or pandemic infectious diseases.
The legislation, which passed on voice vote, also authorizes $160 million in fiscal 2007 and fiscal 2008 for advanced research and development.
Rep. Anna Eshoo, D-Calif., who co-sponsored the legislation with Rep. Mike Rogers, R-Mich., cited the threat of avian influenza or another anthrax attack as reasons for the bill's passage.
House Energy and Commerce Health Subcommittee Chairman Nathan Deal, R-Ga., offered a substitute amendment that made technical changes to the bill. The manager's amendment also passed by voice vote.
